eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

1/2020
vol. 12
 
Share:
Share:
more
 
 
abstract:
Review paper

The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review

Valentina Lancellotta
,
Francesca De Felice
,
Lisa Vicenzi
,
Alfredo Antonacci
,
Valentina Cerboneschi
,
Sara Costantini
,
Daniela di Cristino
,
Luca Tagliaferri
,
Annamaria Cerrotta
,
Andrea Vavassori
,
Sergio Gribaudo
,
Alessandro Colombo
,
Francesco Lucà
,
Raffaele Barbara
,
Monica Mangoni
,
Francesco Marampon
,
Daniela Musio
,
Filippo Bellati
,
Francesco Torcia
,
Vincenzo Tombolini
,
Mattia Falchetto
,
Vitaliana De Sanctis

J Contemp Brachytherapy 2020; 12, 1: 61–66
Online publish date: 2020/02/28
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
Serous adenocarcinoma (uterine serous carcinoma – USC) is a rare and aggressive histologic subtype of endometrial cancer, with a high-rate of recurrence and poor prognosis. The adjuvant treatment for stage I patients is unclear. The purpose of this study was to evaluate the outcomes of stage I USC treated exclusively with chemotherapy plus vaginal brachytherapy (VBT).

Material and methods
A systematic research using PubMed, Scopus, and Cochrane library was conducted to identify full articles evaluating the efficacy of VBT in patients with stage I USC. A search in ClinicalTrials.gov was performed in order to detect ongoing or recently completed trials, and in PROSPERO for searching ongoing or recently completed systematic reviews.

Results
All studies were retrospective and 364 of evaluated patients were found. The average local control was 97.5% (range, 91-100%), the disease free-survival was 88% (range, 82-94%), the overall survival was 93% (range, 72-100%), the specific cancer survival was 89.4% (range, 84.8-94%), and the G3-G4 toxicity was 0-8%.

Conclusions
These data support the concept that in adequately selected patients, VBT alone may be a suitable radiotherapy technique in women with stage I USC who underwent surgical staging and received adjuvant chemotherapy.

keywords:

serous adenocarcinoma, endometrial cancer, brachytherapy, outcomes

 
Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe